Titlesort descending Credit Type Event date Cost
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Administration (Part 2) Enduring $0.00
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Follow up Monitoring Between Cycles (Part 3) Enduring $0.00
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Preparing to Give It (Part 1) Enduring $0.00
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Administration (Part 2) Enduring $0.00
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3) Enduring $0.00
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Preparing to Give It (Part 1) Enduring $0.00
Keeping up with the Chemos Series: Tisotumab Vedotin - Administration (Part 2) Enduring $0.00
Keeping up with the Chemos Series: Tisotumab Vedotin - Follow up Monitoring Between Cycles (Part 3) Enduring $0.00
Keeping up with the Chemos Series: Tisotumab Vedotin - Preparing to Give It (Part 1) Enduring $0.00
Keeping up with the Chemos Series: Trametinib - Administration (Part 2) Enduring $0.00
Keeping up with the Chemos Series: Trametinib - Follow up Monitoring Between Cycles (Part 3) Enduring $0.00
Keeping up with the Chemos Series: Trametinib - Preparing to Give It (Part 1) Enduring $0.00
Keeping Up with the Chemos: Trabectedin and Doxorubicin - Administration (Part 2) Enduring $0.00
Keeping Up with the Chemos: Trabectedin and Doxorubicin - Preparing to Give It (Part 1) Enduring $0.00
Key Concepts of Enhanced Recovery After Surgery. ERAS – How Well Do We Do It? Enduring $0.00

Pages